Erythropoietin (EPO) Increases Myelin Gene Expression in CG4 Oligodendrocyte Cells through the Classical EPO Receptor

Abstract Erythropoietin (EPO) has protective effects in neurodegenerative and neuroinflammatory diseases, including in animal models of multiple sclerosis, where EPO decreases disease severity. EPO also promotes neurogenesis and is protective in models of toxic demyelination. In this study, we asked...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Ilaria Cervellini, Alexander Annenkov, Thomas Brenton, Yuti Chernajovsky, Pietro Ghezzi, Manuela Mengozzi
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: BMC 2013-06-01
Sraith:Molecular Medicine
Ábhair:
Rochtain ar líne:https://doi.org/10.2119/molmed.2013.00013